首页> 外文期刊>Medical dosimetry: official journal of the American Association of Medical Dosimetrists >Dosimetric comparison between volumetric-modulated arc therapy and a hybrid volumetric-modulated arc therapy and segmented field-in-field technique for postmastectomy chest wall and regional lymph node irradiation
【24h】

Dosimetric comparison between volumetric-modulated arc therapy and a hybrid volumetric-modulated arc therapy and segmented field-in-field technique for postmastectomy chest wall and regional lymph node irradiation

机译:体积调制弧疗法与杂交体积调制电弧治疗与杂交体积调制弧治疗和分段现场技术对后切除胸壁和区域淋巴结辐照

获取原文
获取原文并翻译 | 示例
           

摘要

Decreasing radiotoxicity to the heart, lungs, and contralateral breast has proven to lower the risk of secondary malignancy and improve overall outcomes when treating chest wall (CW) and regional lymph nodes in postmastectomy breast cancer patients. In this retrospective study, 11 postmastectomy patients were selected and planned with a novel hybrid treatment method and a traditional volumetric arc therapy (VMAT) approach for comparison. This hybrid technique was able to optimize tangential beams to minimize heart dose and the VMAT contribution to improve dose conformity around the planning target volume (PTV). Overall, this hybrid technique produced more homogenous target dose coverage and demonstrated a decrease of integral dose to organs at risk (OAR), while the VMAT technique demonstrated a higher affinity for maintaining dose conformity. Further observation of dose distributions also revealed that the hybrid plans were more effective in sparing low-dose spread to healthy tissue in both right- and left-sided cases. This observation was made evident by the reduction in heart V5 and D-mean,decreases in all parameters regarding the contralateral lung, as well as all values other than the V20 of the ipsilateral lung. This unique hybrid planning technique could present an alternative to standard intensity-modulated radiation therapy (IMRT) planning when treating postmastectomy CW and regional lymph nodes, as it has shown the capacity to decrease cardiac, lung, and contralateral breast toxicity while maintaining quality PTV coverage. (C) 2019 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.
机译:逐渐减少对心脏,肺和对侧乳房的无抗毒性,以降低继发性恶性肿瘤的风险,并在治疗后切除乳腺癌患者的胸壁(CW)和区域淋巴结时改善整体结果。在这项回顾性研究中,选择并计划具有新的混合治疗方法和传统的体积弧治疗(VMAT)方法来选择并计划11名后切除切除术患者。这种混合技术能够优化切向梁以最小化心脏剂量和VMAT贡献,以改善规划目标体积(PTV)周围的剂量符合性。总体而言,这种混合技术产生了更均匀的靶剂剂量覆盖,并证明了风险(OAR)的整体剂量减少(OAR),而VMAT技术证明了维持剂量符合性的更高亲和力。进一步观察剂量分布也表明,杂交计划在右侧和左侧案件中施加低剂量蔓延至健康组织更有效。通过心脏v5和D-平均值的减少,对对侧肺的所有参数的减少以及v20以外的v20以外的所有值都取得了显而易见的观察结果。当治疗后切除术CW和区域淋巴结时,这种独特的混合规划技术可以呈现标准强度调制的放射治疗(IMRT)规划的替代品,因为它显示了减少心脏,肺和对侧乳腺毒性的能力,同时保持质量PTV覆盖。 (c)2019年美国医学剂量分子协会。由elsevier Inc.保留所有权利发布。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号